Pfizer
Trade Pfizer 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About PFE
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases.
PFE Key Statistics
Stock Snapshot
With a market cap of 139.47B, Pfizer(PFE) trades at $24.50. The stock has a price-to-earnings ratio of 18.53 and currently yields dividends of 7.12%.
During the trading session on 2026-07-13, Pfizer(PFE) shares reached a daily high of $24.72 and a low of $24.22. At a current price of $24.50, the stock is +1.2% higher than the low and still -0.9% under the high.
Trading volume for Pfizer(PFE) stock has reached 42.71M, versus its average volume of 46.76M.
The stock's 52-week range extends from a low of $23.11 to a high of $28.75.
The stock's 52-week range extends from a low of $23.11 to a high of $28.75.
PFE News
BMO Capital lowered the firm’s price target on Pfizer (PFE) to $30 from $34 and keeps an Outperform rating on the shares as part of a broader research note prev...
...
FDA approved PADCEV (enfortumab vedotin-ejfv) plus Keytruda (pembrolizumab) for adult patients with muscle-invasive bladder cancer. The regimen is cleared for...
Analyst ratings
62%
of 29 ratingsMore PFE News
Pfizer ( (PFE) ) has been popular among investors this week. Here is a recap of the key news on this stock. TipRanks Welcomes a New ETF – NYSE:RANK TipRanks has...
Key Points Pfizer has regrouped in the GLP-1 space and is now working on a long-acting drug option. The company's update on the drug's development progress su...
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Unlock powerful investing tools and data-driven insights with TipRanks Premium for more c...
Shares of BridgeBio Pharma BBIO climbed to a 52-week high of $93.42 on Thursday after rival AstraZeneca's AZN late-stage clinical setback boosted investor confi...
McDonald’s or Pfizer: One Offers Real Growth, One Just Pays You to Wait By Trey Thoelcke Published Jul 10, 8:40AM EDT Quick Read MCD and PFE have each slipped...
Transformative AI in healthcare sits at the crossroads of powerful themes investors are watching today: pressure to improve efficiency, closer scrutiny on costs...
A U.S. appeals court on Thursday upheld a ruling for AstraZeneca (AZN) against allegations that its blockbuster lung-cancer drug Tagrisso infringed patents owne...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.